A randomized trial of estrogen or raloxifene during postmenopausal weight loss: Adiposity and cardiometabolic outcomes

OBJECTIVE: Estrogen-based hormone therapy (HT) attenuates abdominal fat gain after menopause, but whether HT improves abdominal fat loss during weight loss is unknown. We hypothesized that HT or a selective estrogen receptor modulator (raloxifene) would augment reductions in abdominal visceral fat d...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Pelt, R.E., Gozansky, W.S., Wolfe, P., Kittelson, J.M., Jankowski, C.M., Schwartz, R.S., Kohrt, W.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968229/
https://www.ncbi.nlm.nih.gov/pubmed/24311443
http://dx.doi.org/10.1002/oby.20653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968229/
https://www.ncbi.nlm.nih.gov/pubmed/24311443
http://dx.doi.org/10.1002/oby.20653

Ejemplares similares